98%
921
2 minutes
20
Introduction: Debate persists on the optimal catheterization method for peritoneal dialysis (PD). This meta-analysis aimed to compare the outcomes of image-guided percutaneous catheterization (IGPC) versus direct visualization catheterization (DVC) for peritoneal dialysis.
Materials And Methods: From the inception of the database until July 16, 2024, four databases (Medline, Embase, Web of Science, and the central database) were searched for literature comparing IGPC versus DVC for peritoneal dialysis. Meta-analyses were conducted on infectious complications, mechanical complications, one-year PD catheter survival, and catheter removal rates.
Results: Totally 11 studies were included in this meta-analysis, comprising a total of 8,981 patients, of which 2,518 patients received IGPC and 6,463 patients received DVC. IGPC exhibited lower rates of infection complications (OR = 0.73, 95% CI: 0.54-0.99, P = 0.04) mechanical complications (OR = 0.64, 95% CI: 0.42-0.99, P = 0.04) and catheter removal compared to DVC (OR = 0.63, 95% CI: 0.50-0.78, P < 0.0001). However, there was no significant difference in one-year PD catheter survival between the two groups (OR = 1.33, 95% CI: 0.78-2.27, P = 0.30).
Conclusions: This meta-analysis concluded that IGPC was a safe and effective catheterization method for PD. The results demonstrated that IGPC significantly reduced the incidence of infection complications, mechanical complications, and catheter removal compared to DVC. No notable disparity in one-year PD survival was detected between the two groups.
Trial Registration: PROSPERO (CRD42024606795).
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12233245 | PMC |
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0325600 | PLOS |
J Thromb Haemost
September 2025
Chronic Disease Research Group, Hennepin Healthcare Research Institute, Minneapolis, MN, USA.
Background: Balancing the risks of thrombotic and bleeding events in people with advanced kidney disease is a clinical challenge.
Objectives: To estimate rates of major adverse thrombotic events (MATEs) and bleeding events in individuals with chronic kidney disease (CKD) stages 4 or 5 or with end-stage kidney disease (ESKD) receiving hemodialysis (HD) or peritoneal dialysis (PD).
Methods: Using administrative claims from a 20% Medicare sample, Optum's de-identified Clinformatics Data Mart Database, and the US Renal Data System from 2016-2019, we identified individuals with CKD stages 4 or 5 and individuals with dialysis-dependent ESKD.
Arq Bras Cardiol
September 2025
Escola Bahiana de Medicina e Saúde Pública, Salvador, BA - Brasil.
Background: Chronic kidney disease (CKD) is associated with a higher prevalence of valvular diseases and increased mortality from cardiovascular causes. Factors that influence the genesis of cardiac valve calcification (CVC) in these patients are not well-defined.
Objective: To determine the risk factors for valvular calcification in patients with CKD.
J Vasc Access
September 2025
Prince of Wales Hospital, Sydney, NSW, Australia.
Objective: Minimal Invasive Dialysis Access (MIDA) for renal dialysis encompasses percutaneous arteriovenous fistula (pAVF) creation and the modified percutaneous Seldinger peritoneal dialysis catheter insertions (pPD). This review examines the impact of MIDA on technical success, maturation rates, patency, clinical benefits, complications, and cost.
Methods: A review was made of the literature on MIDA including pAVF creation and pPD insertion regarding technical success rates, maturation rates, patency, clinical benefits, complications, and cost.
Clin J Am Soc Nephrol
September 2025
Nephrology and Hypertension, Vanderbilt University Medical Center, Nashville, TN, USA.
Clin J Am Soc Nephrol
September 2025
University College London Great Ormond Street Hospital for Children and Institute of Child Health, London, UK.
Background: Experience with icodextrin use in children on long-term peritoneal dialysis is limited. We describe international icodextrin prescription practices and their impact on clinical outcomes: ultrafiltration, blood pressure control, residual kidney function (RKF), technique and patient survival.
Methods: We included patients under 21 years enrolled in the International Pediatric Peritoneal Dialysis Network (IPPN) between 2007 and 2024, on automated PD with a daytime dwell.